InspireMD, Inc. (FRA:II2)

Market Cap	56.35M -17.1%
Revenue (ttm)	6.63M +14.0%
Net Income	-39.38M
EPS	-0.70
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	n/a
Open	1.280
Previous Close	1.300
Day's Range	1.280 - 1.280
52-Week Range	1.280 - 3.480
Beta	n/a
RSI	39.20
Earnings Date	Mar 9, 2026

About InspireMD

InspireMD, Inc., a medical device company, focuses on the development and commercialization of products for the treatment of carotid artery and other vascular diseases in Europe, Latin America, the Middle East, and the Asia Pacific. The company offers CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Stent System, a mesh-covered self-expanding carotid stent; and SwitchGuard neuroprotection system for transcarotid access and neuro protection, as well as treating acute stroke with tandem lesions. ...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2005
• Employees: 66
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: II2

Financial Performance

In 2024, InspireMD's revenue was $7.01 million, an increase of 12.96% compared to the previous year's $6.21 million. Losses were -$32.01 million, 60.7% more than in 2023.

Financial numbers in USD